About Erin R. Conway
Erin Conway focuses her practice on intellectual property and commercial litigation, including Hatch-Waxman/Paragraph IV patent infringement actions and Lanham Act claims for false advertising and unfair competition in both the federal courts and the ITC. Clients trust Erin to efficiently move a case along because of her significant experience in all phases of litigation (trial and appellate levels) including fact and expert discovery, motion practice, claim construction, summary judgment briefing, trials, and appellate briefing. Erin’s litigation experience spans across many technology areas, including pharmaceuticals, computer and software systems, and medical devices. Representative Hatch-Waxman cases involved the drugs Coreg® [carvedilol], Actos® [pioglitazone], Naropin® [ropivacaine], Pennsaid® [diclofenac], Pulmicort Respules® [budesonide], Treanda® [bendamustine], and Colcrys® [colchicines].
In addition to her litigation practice, Erin has experience preparing and prosecuting both U.S. and foreign patents in a variety of technical fields, including in the mechanical, medical and electrical devices, software and computer-based systems. Erin also counsels clients on procurement, enforcement, and licensing of intellectual property rights and provides valuable patent and regulatory landscape evaluations and freedom to operate opinions.
Before joining Amin Talati Wasserman, Erin prosecuted and litigated patents for over nine years at highly respected intellectual property boutique firms in both Chicago and Connecticut. While in law school, Erin was a judicial extern to both Magistrate Judge Arlander Keys of the Northern District of Illinois and the Honorable Richard D. Cudahy of the United States Court of Appeals for the Seventh Circuit. Erin served as an Executive Articles Editor of the Chicago-Kent Law Review.